Chairman and CEO
Prior to founding the company, Damon founded Autotransfusion Services (ATS) in 1991 to provide autotransfusion and PRP products and services to more than 75 hospitals in New York and New Jersey. In 1997, Damon negotiated the acquisition of Hemo Concepts, a New York corporation providing perfusion services for liver transplants at NYU Medical Center and isolated limb perfusion at Memorial Sloan Kettering. During this all-cash transaction, ATS merged with and changed its name to Hemo Concepts, Inc. a New Jersey corporation.
In 1998, just as the AIDS pandemic was peaking, Damon led the company’s effort to become the leader in the field of Bloodless Medicine and Surgery, a strategy that eliminates the need for many donor transfusions. In 1999, Hemo Concepts acquired the Bloodless Medicine and Surgery Institute of Cleveland, Ohio, the only school in the world training physicians and nurses regarding the implementation of these types of programs. Hemo Concepts named its own version of this initiative “Integrated Blood Management” programs.
In 2002, Damon conceptualized, designed, and spearheaded the development of e-BOS, the first internet-based education system to offer online ACCME®-accredited continuing medical education for physicians and nurses seeking to initiate the company’s Integrated Blood Management programs. e-BOS delivered over 25 hours of streaming videos of presentations that were synched to speakers’ written slide presentations and included reference materials along with links allowing users to download original studies and materials. Despite over 25 major medical centers and blood banks in the U.S. and Europe, including Johns Hopkins, Cleveland Clinic, the American Red Cross, and the National Health Service in England, purchasing the company’s Integrated Blood Management program by 2008, the program was ultimately cancelled due to effects of the “Great Recession” of 2007-2009.
Before his immersion in the medical field, Damon worked from 1984 to 1990 as a licensed securities principal, managing multiple brokerage offices while holding Series 24, Series 7, and Series 63 securities, insurance, and real estate licenses.
PhD, Chief Scientific Officer
Richard Carroll is the chief scientific officer at PRP Concepts, Inc. Dick has over 40 years’ experience in developing diagnostics and therapeutics. He has been a leader in eight start-up technology companies that have been acquired and has had senior technology management positions in three corporations. Dick has an expertise in blood cell separation and has developed technologies that have allowed progress in molecular diagnostics and regenerative medicine, with six patent filings and numerous publications. He has organized and led several key clinical studies and has been part of seven FDA 510(k) clearances. Dick has also been VP, business development, for several companies, connecting technologies and opportunities for greater success. Dick has a BS (in biology) and a PhD (in immunology and microbiology) from SUNY Upstate Medical University.
MSN, CCRP, Vice President, Regulatory Affairs and Clinical Research
Noemí Olivo is the vice president of regulatory affairs and clinical research. Noemí has over 25 years of experience in regulatory affairs, quality management, and clinical research with a focus on developing regulatory documentation for medical and in vitro diagnostic device (IVD) device FDA submissions, quality management systems, and clinical research studies. She is a Certified Clinical Research Professional (CCRP) and a member of the Regulatory Affairs Professional Society.
Noemí has held positions as vice president (for regulatory affairs, quality management, and clinical research for medical devices); senior director (for clinical research and quality management for IVD DNA sequencing, and medical device tissue-based cancer diagnostics); and director (for clinical drug trials and medical device studies).
As owner of CRO Services (an Independent CRO), Noemí has been contracted by device manufacturers, health care insurance plans, nonprofit organizations, and educational institutions to develop and oversee their regulatory and quality management infrastructures, prepare regulatory submissions, and to develop and monitor their clinical research studies.
Vice President of Manufacturing
Norm Hutton is the vice president of manufacturing. Norm has over 30 years’ of experience in all aspects of manufacturing, from product development of new products to project management and setting up manufacturing facilities for the high-output manufacture of established medical devices.
Norm has been a leader in the establishment of new manufacturing lines, as well as new manufacturing for companies of all sizes, from start-ups to Fortune 500 companies. Norm’s expertise is in the high-quality manufacture of medical devices in a cost-effective manner, and injection molding of medical devices. In addition, Norm has experience in quality engineering, and is an ISO lead auditor.
Norm has several patent filings and is a holder of four patents for manufacturing applications. Norm has run his own consulting company for the past eight years after a 23-year career with Becton Dickinson as a senior manager of engineering. Norm has a BS (in mechanical engineering) from Syracuse University.
Robert Kent, Jr
Director of Marketing
Robert Kent serves as the director of marketing for the firm in addition to working in his role as president of Timmons&Company, which is a Bucks County, Pennsylvania-based marketing company known for its ability to strategically position and guide companies and provide marketing services.
Bob held leadership positions in sales and marketing for various companies, including Tyco, Siemens, and Philips, before purchasing and beginning his work as the leader of Timmons&Company.
Bob is a high-energy, results-oriented sales and marketing leader with an engineering background and more than 25 years of general management, sales, marketing, and business development experience. He effectively applies his analytical and consultative skill set to effectively conceptualize and implement plans in order to solve client challenges across a broad spectrum of industries (including medical, manufacturing, technology, industrial, and software), thereby measurably impacting their growth and profitability.
Director of Finance
Steve Letts serves as the Director of Finance for the company in addition to his role as a Commercial Advisor at Shell USA where he develops financial models, formulates valuations, and analyzes the economics for Shell’s multi-billion dollar low carbon fuels project portfolio. At Shell, Steve has also conducted financial analysis and reporting for operations in the US, Canada, and Argentina.
Prior to PRP Concepts, Inc. and Shell, Steve served as an officer in the US Coast Guard where he managed teams to conduct Maritime Security and Response Operations in the Philadelphia port area and Law Enforcement in the Caribbean and Gulf of Mexico.
Steve holds a Bachelor of Science in Operations Research from the US Coast Guard Academy, a Master of Business Administration from the Penn State Smeal College of Business, and a Master of Science in Business Analytics from the Carnegie Mellon Tepper School of Business.